Search research articles
Contact Us
Filters
Showing results (31-40 of 312) with videos related to
Page
of 32
Sort By:
Journal of Endourology
|
August 4, 2010
A controlled, randomized, head-to-head comparison of the Prolieve thermodilatation System versus the Targis System for benign prostatic hyperplasia: safety, procedural tolerability, and clinical results
Neal D Shore, Parminder S Sethi
The Journal of Urology
|
February 6, 2026
Reply by Authors
Neal D Shore, Stephen J Freedland
Future Oncology (London, England)
|
March 27, 2025
Enzalutamide in biochemically recurrent prostate cancer: key findings from the EMBARK study
Neal D Shore, Henry H Woo
Future Oncology (London, England)
|
March 25, 2025
Enzalutamide in biochemically recurrent prostate cancer: design and rationale of the EMBARK study
Neal D Shore, Henry H Woo
Reviews in Urology
|
October 6, 2018
Member Census Shows LUGPA Practices Exhibit High Level of Innovation, Sophistication, and Growth
Scott B Sellinger, Neal D Shore
Translational Andrology and Urology
|
April 14, 2025
Historic progression of prostatectomy techniques and associated outcomes
Lauren Folgosa Cooley, Neal D Shore
Reviews in Urology
|
January 6, 2018
Alternative payment models
Deepak A Kapoor, Neal D Shore
Reviews in Urology
|
April 30, 2010
Intermittent androgen deprivation therapy: redefining the standard of care?
Neal D Shore, E David Crawford
Urologic Oncology
|
December 23, 2022
Clinical and economic impact of blue light cystoscopy in the management of NMIBC at US ambulatory surgical centers: what is the site-of-service disparity?
Neal D Shore, Meghan B Gavaghan
The Journal of Urology
|
February 6, 2026
Reply by Authors
Neal D Shore, Stephen J Freedland
Page
of 32
Search research articles
Search
Showing results (31-40 of 312) with videos related to
Sort By:
Page
of 32
Journal of Endourology
|
August 4, 2010
A controlled, randomized, head-to-head comparison of the Prolieve thermodilatation System versus the Targis System for benign prostatic hyperplasia: safety, procedural tolerability, and clinical results
Neal D Shore, Parminder S Sethi
The Journal of Urology
|
February 6, 2026
Reply by Authors
Neal D Shore, Stephen J Freedland
Future Oncology (London, England)
|
March 27, 2025
Enzalutamide in biochemically recurrent prostate cancer: key findings from the EMBARK study
Neal D Shore, Henry H Woo
Future Oncology (London, England)
|
March 25, 2025
Enzalutamide in biochemically recurrent prostate cancer: design and rationale of the EMBARK study
Neal D Shore, Henry H Woo
Reviews in Urology
|
October 6, 2018
Member Census Shows LUGPA Practices Exhibit High Level of Innovation, Sophistication, and Growth
Scott B Sellinger, Neal D Shore
Translational Andrology and Urology
|
April 14, 2025
Historic progression of prostatectomy techniques and associated outcomes
Lauren Folgosa Cooley, Neal D Shore
Reviews in Urology
|
January 6, 2018
Alternative payment models
Deepak A Kapoor, Neal D Shore
Reviews in Urology
|
April 30, 2010
Intermittent androgen deprivation therapy: redefining the standard of care?
Neal D Shore, E David Crawford
Urologic Oncology
|
December 23, 2022
Clinical and economic impact of blue light cystoscopy in the management of NMIBC at US ambulatory surgical centers: what is the site-of-service disparity?
Neal D Shore, Meghan B Gavaghan
The Journal of Urology
|
February 6, 2026
Reply by Authors
Neal D Shore, Stephen J Freedland
Page
of 32